MPTP-induced central dopamine depletion exacerbates experimental autoimmune encephalomyelitis (EAE) in C57BL mice

Inflammation Research

Volumn 56, Issue 8, 2007, Pages 311-317

  Balkowiec Iskra E ^a   Kurkowska Jastrzebska, I ^b   Joniec, I ^a   Ciesielska, A ^b   Muszynska, A ^a   Przybylkowski A ^a   Czlonkowska A ^a,b   Czlonkowski A ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

Author keywords

Dopamine; Dopaminergic system; Experimental autoimmune encephalomyelitis; IL 1 ; MPTP; TGF

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DOPAMINE; FREUND ADJUVANT;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NEUROTOXICITY; NONHUMAN; PATHOGENESIS; TISSUE SECTION;

ANIMALS; CORPUS STRIATUM; DOPAMINE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON TYPE II; INTERLEUKIN-1BETA; MALE; MICE; MICE, INBRED C57BL; MPTP POISONING; RNA, MESSENGER; SPINAL CORD; TRANSFORMING GROWTH FACTOR BETA;

EID: 34547777412     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-007-6128-0     Document Type: Article

References (28)

1. Bradl M, Linington C. Animal model of demyelination. Brain Pathol 1996; 6: 303-11.
2. Polman CH, Dijkstra CD, Sminia T, Koetsier JC. Immunohistological analysis of macrophages in the central nervous system of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 1986; 11: 215-21.
3. Pal E, Yamamura T, Tabira T. Autonomic regulation of experimental autoimmune encephalomyelitis in IL-4 knockout mice. J Neuroimmunol 1999; 100: 149-55.
4. Członkowska A, Kohutnicka M, Kurkowska-Jastrzebska I, Członkowski A. Microgliala reaction in MPTP-induced Parkinson's disease mice model. Neurodegeneration 1996; 5: 137-43.
5. Renoux G, Biziere K, Renoux M, Steinberg R, Kann JP, Guillaumin JM. Sodium diethyldithiocarbamate protects against MPTP-induced inhibition of immune responses in mice. Life Sci 1989; 44: 771-7.
6. Bieganowska K, Członkowska A, Bidzinski A, Mierzewska H, Korlak J. Immunological changes in the MPTP-induced Parkinson's disease mouse model. J Neuroimmunol 1993; 42: 33-8.
7. Bieganowska K, Członkowska A, Korlak J. Pargyline pretreatment prevents immunological changes induced by MPTP in mice. Immunopharmacology 1996; 35: 149-54.
8. Basu S, Dasgupta PS, Roychowdhury J. Enhanced tumor growth in brain dopamine-depleted mice following 1-methyl-4-phenyl-1,2,3,6-tetrahydropiridine (MPTP) treatment. J Neuroimmunol 1995; 60: 1-8.
9. Cross RJ, Jackson JC, Brooks WH, Sparks DL, Marksberry WR, Rozman TL.Neuroimmunomodulation: imapirement of humoral immune responsiveness by 6-hydroxydopamine treatment. Immunology 1986; 57: 145-52.
10. NisticoG, Caroleo MC, Arbitrio M, Pulvirenti L. Evidence for an involvement of dopamine D1 receptors in the limbic system in the control of immune mechanisms. Neuroimmunomodulation 1994; 1: 174-80.
11. Chelmicka-Schorr E, Kwasniewski MN, Wollmann RL. Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis. J Neuroimmunol 1992; 37: 99-103.
12. Karpus WJ, Konkol RJ, Killen JA. Central catecholamine neurotoxin administration. Immunological changes associated with the suppression of experimental autoimmune encephalomyelitis. J Neuroimmunol 1988; 18: 61-73.
13. Stosic-Grujicic S, Savic-Radojevic A, Maksimovic-Ivanic D, Markovic M, Bumbasirevic V, Ramic Z, Mostarica-Stojkovic M. Down-regulation of experimental allergic encephalomyelitis in DA rats by tiazofurin. J Neuroimmunol 2002; 130: 66-77.
14. Fiszer U. Badanie stanu immunologicznego u osób z chorob Parkinsona z uwzgl dnieniem wpływu leczenia lewodop . Doniesienie wstepne. Neurol Neurochir Pol 1989; 23: 7-11.
15. Chiba S, Matsumoto H, Saitoh M, Kasahra M, Matsuya M, Kashiwagi MA. A correlation study between serum adenosine deaminase activities and peripheral lymphocyte subsets in Parkinson's disease. J Neurol Sci 1995; 132: 170-3.
16. White SR, Bhatnagar RK, Bardo MT. Norepinephrine depletion in the spinal cord gray matter of rats with experimental allergic encephalomyelitis. J Neurochem 1983; 40: 1771-3.
17. Krenger W, Honegger CG, Feurer C, Cammisuli S. Changes of neurotransmitter systems in chronic relapsing experimental allergic encephalomyelitis in rat brain and spinal cord. J Neurochem. 1986; 47: 247-54.
18. Hofstetter HH, Messner R, Lesch KP, Linker RA, Toyka KV, Gold R. Absencje of reuptake of serotonin influence, susceptibility to clinical autoimmune disease and neuroantigen-specific interferongamma production in mouse EAE. Clinic Exp Immunol 2005; 142: 39-44.
19. Chelmicka-Schorr E, Kwasniewski MN, Wollmann RL. Sympathectomy augments adoptively transferred experimental allergic encephalomyelitis. J Neuroimmunol 1992; 37: 99-103.
20. Miles K, Chelmicka-Schorr E, Otten G, Arnason BGW. Sympathetic nervous system and immune response in mice. Neurology 1984; 34: 259.
21. Symons JA, Bundick RV, Suckling AJ, Rumsby MG. Cerebrospinal fluid IL-1 like activity during chronic relapsing experimental allergic encephalomyelitis. Clin Exp Immunol 1987; 68: 648-54.
22. Wang Chen Xu, Shuaib A. Involvement of inflammatory cytokines in central nervous system injury. Prog Neurobiol 2002; 67: 161-72.
23. Giulian D, Woodward J,Young DG, Krebs JF, Lachman LB. IL-1 injected into mammalian brain stimulates astrioglosis and neovascularization. J Neurosci 1989; 8: 2485-90.
24. Pollak Y,Ovadia H, Orion E, Yirmiya R. The EAE-associated behavioral syndrome: Modulation by anti-inflammatory treatments. J Neuroimmunol 2003; 137: 100-8.
25. Benveniste EN. Cytokine actions in the CNS. Cyt & Growth Fact Rev 1998; 9: 259-75.
26. Cautain B, Damoiseaux J, Bernard I, van Straaten H, van Breda Vriesman P, Boneu B et al. Essential role of TGF-beta in the natural resistance to experimental allergic encephalomyelitis in rats. Eur J Immunol 2001; 31: 1132-40.
27. Szczepanik M, Tutaj M, Bryniarski K, Dittel BN. Epicutaneously induced TGF-beta-dependent tolerance inhibits experimental autoimmune encephalomyelitis. J Neuroimmunol 2005; 164: 105-14.
28. Tanuma N, Shin T, Matsumoto Y. Characterization of acute versus chronic relapsing autoimmune encephalomyelitis in DA rats. J Neuroimmunol. 2000; 108: 171-80.